Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease (BEAM)
Sponsor: Wake Forest University Health Sciences
Listed as NCT02984540, this NA trial focuses on Insulin Resistance and Mild Cognitive Impairment and remains completed. Sponsored by Wake Forest University Health Sciences, it has been updated 11 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Aug 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Aug 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Sep 2020 — Jan 2021 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Jan 2019 — Sep 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2018 — Jan 2019 [monthly]
Active Not Recruiting NA
-
Aug 2018 — Sep 2018 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Active Not Recruiting NA
First recorded
Feb 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .